-
Mashup Score: 0Program Planner - 4 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Program Planner - 4 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Planner - 4 year(s) ago
One fine body?
Source: www.abstractsonline.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types - 4 year(s) ago
The T cell-inflamed tumor microenvironment, characterized by CD8 T cells and type I/II interferon transcripts, is an important cancer immunotherapy biomarker. Tumor mutational profile may also dictate response with some oncogenes (i.e. WNT/β-catenin) known to mediate immuno-suppression. Building on these observations we performed a multi-omic analysis of human cancer correlating the T…
Source: bioRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
@chadinabhan @weldeiry @StephenVLiu @cancerassassin1 @PatrickCMa1 @carisls Thanks & learned lots. @weldeiry is the master of TP53. We discussed the complicated interplay of TP53 on #immunotherpay at #AACR20 Virtual 1. Thanks to @carisls Translational Research group for allowing us to present our work/concept! @RiyueSunnyBao https://t.co/VbyW1agrhV https://t.co/qTDu736wGC
-
-
Mashup Score: 0Cancer Research: 80 (16 Supplement) - 4 year(s) ago
AACR PublicationsBlood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Clinical Cancer Research Molecular Cancer Research Molecular Cancer Therapeutics …
Source: Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Cancer Research: 80 (16 Supplement) - 4 year(s) ago
AACR PublicationsBlood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Clinical Cancer Research Molecular Cancer Research Molecular Cancer Therapeutics …
Source: Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cancer Research: 80 (16 Supplement) - 4 year(s) ago
AACR PublicationsBlood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Clinical Cancer Research Molecular Cancer Research Molecular Cancer Therapeutics …
Source: Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Cancer Research: 80 (16 Supplement) - 4 year(s) ago
AACR PublicationsBlood Cancer Discovery Cancer Discovery Cancer Epidemiology, Biomarkers & Prevention Cancer Immunology Research Cancer Prevention Research Cancer Research Clinical Cancer Research Molecular Cancer Research Molecular Cancer Therapeutics …
Source: Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Ammar Chaudhry, MD @cityofhope @AACR #AACR20 #glioblastoma Randiomic prediction of survival in recurrent high-grade glioma patients - 4 year(s) ago
Ammar Chaudhry, MD at City of Hope discusses an abstract from AACR 2020 entitled Randiomic prediction of survival in recurrent high-grade glioma patients
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Marwan Fakih, MD at City of Hope discusses an abstract from AACR20 entitled Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study Abstract Purpose: KEYNOTE-158 (ClinicalTrials.gov identifier: NCT02628067) investigated the efficacy and safety of pembrolizumab across multiple cancers. We present results from…
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Pneumonitis incidence in Pts w/ NSCLC treated w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. @Aurora_Cancer @Syapse @FDAOncology #AACR20 CT086 - VCTPL08 https://t.co/VkpILtNFbu #lcsm #irAE #ImmunoOnc #radonc https://t.co/3Wu419ZfVB